NCT04057547 Efficacy and Safety of Modified Gegen Qinlian Decoction for Ulcerative Colitis With Damp-heat Syndrome Status UNKNOWN Phase EARLY_PHASE1
NCT04034758 Safety and Efficacy of Heterologous FMT by SQIMC-md Capsule in Mild-moderate Ulcerative Colitis Patients Status UNKNOWN Phase NA
NCT04033445 A Study of Guselkumab in Participants With Moderately to Severely Active Ulcerative Colitis Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT04032652 Use of Rectal Dialysis Technique to Measure Rectal 5-ASA Levels in Healthy Volunteers Receiving Asacol Status TERMINATED Phase PHASE2
NCT04031482 TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate Partners Status UNKNOWN Phase N/A
NCT04029649 Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis Status UNKNOWN Phase PHASE2/PHASE3
NCT04023396 Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT04018599 Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS Status COMPLETED Phase PHASE1
NCT04006080 Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis Status UNKNOWN Phase PHASE4
NCT04004611 A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) Status COMPLETED Phase PHASE2
NCT04000139 Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT03998488 Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT03996369 Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE3